Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.
Bernie Endyarni MediseSoedjatmiko SoedjatmikoIris RengganisHartono GunardiRini SekartiniSukamto KoesnoHindra Irawan SatariSri Rezeki HadinegoroJae Seung YangJean-Louis ExclerSushant SahastrabuddheMita PuspitaRini Mulia SariNovilia Sjafri BachtiarPublished in: PloS one (2019)
The Vi-DT vaccine is safe and immunogenic in adults and children older than two years. A single dose of the vaccine is able to produce seroconversion and high GMT in all individuals.